UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 6, 2001
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
1-3433 (Commission file number) |
38-1285128 (I.R.S. Employer Identification No.) |
2030 DOW CENTER, MIDLAND, MICHIGAN 48674
(Address of principal executive offices) (Zip Code)
Registrant's
telephone number, including area code: 517-636-1000
Effective April 7, 2001, the area code for Midland, Michigan will change from 517 to 989.
Not applicable
(Former name, former address and former fiscal year, if changed since last report)
Item 7. Financial Statements and Exhibits.
This Current Report on Form 8-K/A is being filed as an amendment to the Current Report on Form 8-K filed by The Dow Chemical Company on February 20, 2001, describing the merger with Union Carbide Corporation.
The financial statements of businesses acquired are incorporated herein by reference to the financial statements, including notes to financial statements, contained in the Union Carbide Corporation Annual Report on Form 10-K for the year ended December 31, 2000, filed with the U.S. Securities and Exchange Commission on March 8, 2001.
The following describes the pro forma effect of the merger of The Dow Chemical Company and Union Carbide Corporation as required pursuant to Article 11 of Regulation S-X.
2
Unaudited Pro Forma Combined Condensed Financial Information
The following describes the pro forma effect of the merger on the historical condensed statements of income for the years ended December 31, 2000, 1999 and 1998 and the historical condensed balance sheet as of December 31, 2000 of The Dow Chemical Company and Union Carbide Corporation under the assumptions and adjustments described below.
The pro forma adjustments reflect the application of the pooling of interests method of accounting for a business combination. The unaudited pro forma combined condensed financial information and the accompanying notes should be read in conjunction with the historical financial statements and related notes of Union Carbide Corporation (incorporated by reference in this Current Report on Form 8-K/A) and The Dow Chemical Company.
The unaudited pro forma combined condensed financial information is provided for informational purposes only and does not purport to represent what the combined financial position and results of operations would actually have been had the merger and other pro forma adjustments in fact occurred at the dates indicated. The following unaudited pro forma combined condensed statements of income and unaudited pro forma combined condensed balance sheet illustrate the estimated effects of the merger as if that transaction had occurred for the statements of income as of January 1, 1998 and for the balance sheet as of December 31, 2000. The unaudited pro forma combined condensed statements of income do not include the impact of all the nonrecurring charges or credits directly attributable to the transaction.
For financial accounting purposes, the merger has been accounted for using the pooling of interests method of accounting. Accordingly, the recorded historical cost basis of the assets and liabilities of The Dow Chemical Company and Union Carbide Corporation have been carried forward to the combined company and the historical results of operations of the separate companies for all fiscal years before the merger have been combined. No adjustments have been made to the historical financial statements of The Dow Chemical Company or Union Carbide Corporation to conform the accounting policies of the combining companies as the nature and amounts of such adjustments are not significant. In addition, no adjustments have been made in the unaudited pro forma combined condensed financial information for transactions between The Dow Chemical Company and Union Carbide Corporation as such transactions were determined to be immaterial.
3
Unaudited Pro Forma Combined Condensed Balance Sheet
December 31, 2000
(in millions)
|
The Dow Chemical Company |
Union Carbide Corporation |
Merger Pro Forma Adjustments |
Combined Pro Forma |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||
Current Assets | ||||||||||||||
Cash and cash equivalents | $ | 215 | $ | 63 | $ | (51 | )(1) | $ | 227 | |||||
Accounts and notes receivable | 5,385 | 1,034 | | 6,419 | ||||||||||
Inventories | 3,463 | 750 | | 4,213 | ||||||||||
Other current assets | 197 | 329 | (113 | )(2) | 413 | |||||||||
Total current assets | 9,260 | 2,176 | (164 | ) | 11,272 | |||||||||
Investments | ||||||||||||||
Investment in nonconsolidated affiliates | 1,088 | 1,008 | | 2,096 | ||||||||||
Other investments and noncurrent receivables | 2,951 | 97 | 154 | (2) | 3,202 | |||||||||
Total investments | 4,039 | 1,105 | 154 | 5,298 | ||||||||||
Net Property | 9,190 | 4,521 | | 13,711 | ||||||||||
Total Other Assets | 5,156 | 544 | (67 | )(1) | 5,592 | |||||||||
(41 | )(2) | |||||||||||||
Total Assets | $ | 27,645 | $ | 8,346 | $ | (118 | ) | $ | 35,873 | |||||
Liabilities and Stockholders' Equity |
||||||||||||||
Current Liabilities | ||||||||||||||
Notes payable and long-term debt due within one year | $ | 1,659 | $ | 1,178 | | $ | 2,837 | |||||||
Accounts payable | 3,799 | 342 | $ | 428 | (2) | 4,569 | ||||||||
Other current liabilities | 2,415 | 780 | (428 | )(2) | 2,767 | |||||||||
Total current liabilities | 7,873 | 2,300 | | 10,173 | ||||||||||
Long-Term Debt | 4,865 | 1,748 | | 6,613 | ||||||||||
Other Noncurrent Liabilities | ||||||||||||||
Deferred income tax liabilities noncurrent | 887 | | 278 | (2) | 1,165 | |||||||||
Pension and other postretirement benefits noncurrent | 1,746 | 434 | 58 | (2) | 2,238 | |||||||||
Other noncurrent obligations | 2,178 | 1,170 | (336 | )(2) | 3,012 | |||||||||
Total other noncurrent liabilities | 4,811 | 1,604 | | 6,415 | ||||||||||
Minority Interest in Subsidiaries | 410 | 40 | | 450 | ||||||||||
Preferred Securities of Subsidiary | 500 | | | 500 | ||||||||||
Stockholders' Equity | ||||||||||||||
Common stock | 2,453 | 159 | (159 | )(3) | 2,453 | |||||||||
Additional paid-in capital | 16 | 217 | (233 | )(3) | | |||||||||
Unearned ESOP shares | (53 | ) | (50 | ) | | (103 | ) | |||||||
Retained earnings | 14,071 | 3,572 | (4,968 | )(3) | 12,557 | |||||||||
(118 | )(1) | |||||||||||||
Accumulated other comprehensive loss | (336 | ) | (224 | ) | | (560 | ) | |||||||
Treasury stock at cost | (6,965 | ) | (1,020 | ) | 5,360 | (3) | (2,625 | ) | ||||||
Net stockholders' equity | 9,186 | 2,654 | (118 | ) | 11,722 | |||||||||
Total Liabilities and Stockholders' Equity | $ | 27,645 | $ | 8,346 | $ | (118 | ) | $ | 35,873 | |||||
4
Unaudited Pro Forma Combined Condensed Statement of Income (5)
For the Year Ended December 31, 2000
(in millions, except per share data)
|
The Dow Chemical Company |
Union Carbide Corporation |
Merger Pro Forma Adjustments |
Combined Pro Forma |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | $ | 23,008 | $ | 6,526 | | $ | 29,534 | ||||||
Cost of sales | 18,262 | 5,531 | $ | 338 (2) | 24,131 | ||||||||
Research and development expenses | 892 | 152 | 75 (2) | 1,119 | |||||||||
Selling, general and administrative expenses | 1,582 | 247 | (4)(2) | 1,825 | |||||||||
Amortization of intangibles | 125 | | 14 (2) | 139 | |||||||||
Depreciation and amortization | | 423 | (423)(2) | | |||||||||
Purchased in-process research and development charges | 6 | | | 6 | |||||||||
Insurance and finance company operations, pretax income | 68 | | 17 (2) | 85 | |||||||||
Partnership loss | | (40 | ) | 40 (2) | | ||||||||
Equity in earnings of nonconsolidated affiliates | 271 | 123 | (40)(2) | 354 | |||||||||
Sundry income net | 309 | 87 | (44)(2) | 352 | |||||||||
Earnings before Interest, Income Taxes and Minority Interests | 2,789 | 343 | (27) | 3,105 | |||||||||
Interest income | 119 | | 27 (2) | 146 | |||||||||
Interest expense and amortization of debt discount | 507 | 158 | | 665 | |||||||||
Income before Income Taxes and Minority Interests | 2,401 | 185 | | 2,586 | |||||||||
Provision for income taxes | 823 | 16 | | 839 | |||||||||
Minority interests' share in income | 65 | 7 | | 72 | |||||||||
Net Income Available for Common Stockholders | $ | 1,513 | $ | 162 | | $ | 1,675 | ||||||
Share Data | |||||||||||||
Earnings per common share basic | $ | 2.24 | $ | 1.20 | (4) | $ | 1.88 | ||||||
Earnings per common share diluted | $ | 2.22 | $ | 1.18 | (4) | $ | 1.85 | ||||||
Weighted-average common shares outstanding basic | 676.0 | 134.8 | (4) | 893.2 | |||||||||
Weighted-average common shares outstanding diluted | 683.0 | 137.5 | (4) | 904.5 | |||||||||
5
Unaudited Pro Forma Combined Condensed Statement of Income (5)
For the Year Ended December 31, 1999
(in millions, except per share data)
|
The Dow Chemical Company |
Union Carbide Corporation |
Merger Pro Forma Adjustments |
Combined Pro Forma |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | $ | 19,989 | $ | 5,870 | | $ | 25,859 | |||||||
Cost of sales | 15,362 | 4,609 | $ | 329 | (2) | 20,300 | ||||||||
Research and development expenses | 845 | 154 | 76 | (2) | 1,075 | |||||||||
Selling, general and administrative expenses | 1,530 | 257 | (11 | )(2) | 1,776 | |||||||||
Amortization of intangibles | 146 | | 14 | (2) | 160 | |||||||||
Depreciation and amortization | | 408 | (408 | )(2) | | |||||||||
Purchased in-process research and development charges | 6 | | | 6 | ||||||||||
Special charges | 94 | | | 94 | ||||||||||
Insurance and finance company operations, pretax income | 127 | | 23 | (2) | 150 | |||||||||
Partnership income | | 11 | (11 | )(2) | | |||||||||
Equity in earnings of nonconsolidated affiliates | 82 | 2 | 11 | (2) | 95 | |||||||||
Sundry income net | 261 | 102 | (34 | )(2) | 329 | |||||||||
Earnings before Interest, Income Taxes and Minority Interests | 2,476 | 557 | (11 | ) | 3,022 | |||||||||
Interest income | 121 | | 11 | (2) | 132 | |||||||||
Interest expense and amortization of debt discount | 431 | 133 | | 564 | ||||||||||
Income before Income Taxes and Minority Interests | 2,166 | 424 | | 2,590 | ||||||||||
Provision for income taxes | 766 | 108 | | 874 | ||||||||||
Minority interests' share in income | 69 | 5 | | 74 | ||||||||||
Preferred stock dividends | 5 | | | 5 | ||||||||||
Income before Cumulative Effect of Change in Accounting Principle | 1,326 | 311 | | 1,637 | ||||||||||
Cumulative effect of change in accounting principle | | (20 | ) | | (20 | ) | ||||||||
Net Income Available for Common Stockholders | $ | 1,326 | $ | 291 | | $ | 1,617 | |||||||
Share Data | ||||||||||||||
Earnings before cumulative effect of change in accounting principle per common share basic | $ | 2.01 | $ | 2.33 | (4) | $ | 1.87 | |||||||
Earnings per common share basic | $ | 2.01 | $ | 2.18 | (4) | $ | 1.85 | |||||||
Earnings before cumulative effect of change in accounting principle per common share diluted | $ | 1.98 | $ | 2.27 | (4) | $ | 1.84 | |||||||
Earnings per common share diluted | $ | 1.98 | $ | 2.13 | (4) | $ | 1.82 | |||||||
Weighted-average common shares outstanding basic | 660.2 | 133.3 | (4) | 874.9 | ||||||||||
Weighted-average common shares outstanding diluted | 673.3 | 136.7 | (4) | 893.5 | ||||||||||
6
Unaudited Pro Forma Combined Condensed Statement of Income (5)
For the Year Ended December 31, 1998
(in millions, except per share data)
|
The Dow Chemical Company |
Union Carbide Corporation |
Merger Pro Forma Adjustments |
Combined Pro Forma |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | $ | 19,442 | $ | 5,659 | | $ | 25,101 | ||||||
Cost of sales | 14,800 | 4,294 | $ | 301 | (2) | 19,395 | |||||||
Research and development expenses | 807 | 143 | 76 | (2) | 1,026 | ||||||||
Selling, general and administrative expenses | 1,666 | 304 | (6 | )(2) | 1,964 | ||||||||
Amortization of intangibles | 88 | | 18 | (2) | 106 | ||||||||
Depreciation and amortization | | 389 | (389 | )(2) | | ||||||||
Purchased in-process research and development charges | 349 | | | 349 | |||||||||
Special charges | 458 | | | 458 | |||||||||
Insurance and finance company operations, pretax income | 112 | | 12 | (2) | 124 | ||||||||
Partnership income | | 33 | (33 | )(2) | | ||||||||
Equity in earnings (losses) of nonconsolidated affiliates | 64 | (66 | ) | 33 | (2) | 31 | |||||||
Sundry income net | 916 | 241 | (22 | )(2) | 1,135 | ||||||||
Earnings before Interest, Income Taxes and Minority Interests | 2,366 | 737 | (10 | ) | 3,093 | ||||||||
Interest income | 139 | | 10 | (2) | 149 | ||||||||
Interest expense and amortization of debt discount | 493 | 114 | | 607 | |||||||||
Income before Income Taxes and Minority Interests | 2,012 | 623 | | 2,635 | |||||||||
Provision for income taxes | 685 | 217 | | 902 | |||||||||
Minority interests' share in income | 17 | 3 | | 20 | |||||||||
Preferred stock dividends | 6 | | | 6 | |||||||||
Net Income Available for Common Stockholders | $ | 1,304 | $ | 403 | | $ | 1,707 | ||||||
Share Data | |||||||||||||
Earnings per common share basic | $ | 1.94 | $ | 2.98 | (4) | $ | 1.92 | ||||||
Earnings per common share diluted | $ | 1.92 | $ | 2.91 | (4) | $ | 1.89 | ||||||
Weighted-average common shares outstanding basic | 670.6 | 135.0 | (4) | 888.1 | |||||||||
Weighted-average common shares outstanding diluted | 681.8 | 138.4 | (4) | 904.8 | |||||||||
7
Notes to Unaudited Pro Forma Combined Condensed Financial Information
(in millions, except per share amounts)
8
See Exhibit Index below for exhibits filed with the Current Report on Form 8-K/A
9
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE DOW CHEMICAL COMPANY Registrant |
||
/s/ FRANK H. BROD Frank H. Brod Vice President and Controller |
Date: April 4, 2001
10
Exhibit No. |
|
|
---|---|---|
23 | Independent Auditors' Consent. |
11